Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05731284
NA

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate the surgical outcomes of injecting platelet-rich plasma (PRP) into the vaginal tissue as an adjunct therapy at the time of prolapse surgery

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2023-07-01

Completion Date

2028-12-31

Last Updated

2025-07-04

Healthy Volunteers

No

Interventions

PROCEDURE

Platelet rich plasma (PRP) Injection

Randomly picked (like the flip of a coin) by a computer to receive either platelet-rich plasma (PRP) or normal saline. This is a double-blind study. During vaginal prolapse surgery, the surgeon will inject PRP into the vaginal tissue at the surgical site.

PROCEDURE

Placebo

Normal saline Injection

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States